Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.
about
A functional isoform of the human granulocyte/macrophage colony-stimulating factor receptor has an unusual cytoplasmic domainGranulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.Novel Therapies for Eosinophilic DisordersAntiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS modelGM-CSF in busulfan overdosageHematopoietic growth factors in clinical hematology.Pathogenesis of HIV-1 infection within bone marrow cells.Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Reduces Pancytopenia After Rescue Therapy in a Patient with Hodgkin's Lymphoma.A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor.Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patientsMedical and virological aspects of ocular human immunodeficiency virus infection for the ophthalmologist.Divergent disease patterns in granulocyte-macrophage colony-stimulating factor transgenic mice associated with different transgene insertion sitesHuman granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factorsA randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.Clinical applications of recombinant human colony-stimulating factors.Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor.Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitroRegulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor.Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.Hemopoietic colony growth-promoting activities in the plasma of bone marrow transplant recipients.Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.Response of simian virus 40 (SV40)-transformed, cultured human marrow stromal cells to hematopoietic growth factors.Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alphaProtective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic miceAlteration of the functional effects of granulocyte-macrophage colony-stimulating factor on polymorphonuclear leukocytes by membrane-fluidizing agents.Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.Hemopoietic growth factors: a review.Specific human granulocyte-macrophage colony-stimulating factor antagonists.Retinoids in cancer treatment.The cytokines are comingColony-stimulating factors: a new step in clinical practice. Part I.Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.The potential role of recombinant hematopoietic colony-stimulating factors in preventing infections in the immunocompromised hostPhase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerAntiviral therapy: current concepts and practicesMechanisms of eosinophilia in the pathogenesis of hypereosinophilic disordersContinuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously
P2860
Q24562886-7562AB07-4AB8-4651-8F01-339AFB861CB3Q24814373-9EDB73C0-6068-49AF-B6EF-11AA0C60F4B4Q26799600-10D0F73C-0570-449F-AB2F-9EBAE946E6BDQ28323375-1BB7D746-DD21-4B7F-A559-D925577FEE9EQ28331759-6AD9B32F-BFAB-4A42-AA7E-2DE28CC9FC47Q30444416-AFCFF035-B4FB-44BC-AE46-FF344F508FC7Q33334766-FCD84576-B2A7-4817-90D1-80D993B70BDFQ33393724-E5709DF4-AA6A-4377-BCAF-7CFBE6D6336DQ33434130-1A00A4F0-45C7-4DFC-AB20-23C9633AFECDQ33559130-A6D6DF64-AADE-497C-A1CD-E174F06D09D8Q33567525-D74E134D-2DBF-4E17-8B6B-0FE90753375FQ33569593-A729C6ED-4A36-4396-96A0-9EECC64CA849Q33657285-CDF643D7-0748-499F-ACA7-1146F87D5E28Q33682051-E1A1FD90-E76D-4B5A-AAE4-F2ED7D5330AFQ33837333-9F76EC80-C321-44BF-A848-DDCEAE28B7A7Q33998299-6A6CE74B-6E0F-4A39-A736-C7EAAF4948B5Q34102759-4C482DDF-0F89-4845-903F-ED926702AECCQ34169269-0A557837-0246-4D34-8AAB-53B208068C91Q34238159-42510DB4-7928-48B5-B95B-99084811B813Q34246280-F7C3B19D-A2A5-4656-8183-953367188FEAQ34304474-C67CFAC0-FB60-45AE-89D5-D8747EDF1A83Q34378498-6F6ACBE5-4090-4DD1-A0A2-E28147F6DBC1Q34557686-991C736B-AF3E-448B-9A1A-E75F007DE5EAQ34566504-C4E50883-64CF-45D8-BF45-0B76F9FBB1CFQ34566713-CCA2BFB1-2F88-4BB9-9CC8-8C8D86090868Q35088444-336BDB4F-304A-4730-BA6C-08CE30601F6CQ35097178-708E7F4F-60B7-46A3-8C17-214B5E564C1FQ35104358-E1DB5B3D-CB1C-4B98-B9F4-6A0B8685A815Q35232016-EB629B36-CF1F-43C6-950A-C5D8ED4C18A4Q35328369-E18B557D-2CED-49C8-9D07-82224DB995A8Q35536111-1ACE94FC-0FD4-4D74-A93B-6175BFA6681EQ35536280-5EA1BD58-C424-42B9-A3E1-61FC635D9456Q35625775-67E29FD4-BAB1-423F-B7CD-2D287FF486CCQ35659605-4CD3418A-9219-4227-AAE9-74F2B7715E48Q35810392-8798C054-55E7-488B-8B30-9132A2FCF047Q35893155-5C368862-D2F0-420C-A421-CA377EE8ECB1Q36029532-35829006-52BE-404E-A752-B847AA1C8850Q36070394-5FB76DE4-6726-482C-9CF3-E707E7C3046FQ36119800-8122FD48-1D8F-405E-A2C2-5D884D49BA12Q36140972-4454A9C2-67E8-4B83-A496-504771554A5B
P2860
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Effect of recombinant human gr ...... red immunodeficiency syndrome.
@en
type
label
Effect of recombinant human gr ...... red immunodeficiency syndrome.
@en
prefLabel
Effect of recombinant human gr ...... red immunodeficiency syndrome.
@en
P2093
P1476
Effect of recombinant human gr ...... red immunodeficiency syndrome.
@en
P2093
P304
P356
10.1056/NEJM198709033171003
P407
P577
1987-09-01T00:00:00Z